New US biotech hubs showing potential amid onshoring request
Ever since its early roots, the US has been a key player in the pharmaceutical industry, with prominent names like…
Trump Tariffs
-
-
AstraZeneca inks Trump drug pricing deal amid tariff threats
UK-Swedish pharmaceutical giant AstraZeneca has signed a drug pricing deal with the US government, becoming the second industry titan to…
-
Drugmakers point to US expansion plans amid Trump’s 100% drug tariff
The US will impose a 100% tariff on certain pharma products entering the country, the latest move by the Trump…
-
Business concerns about tariffs continue to rise
Concerns about tariffs among businesses globally have continued to rise significantly over the last six months, according to a new…
-
CapVest to buy control of generics giant Stada in €10bn deal
CapVest Partners has agreed to purchase a majority stake in German generics manufacturer Stada Arzneimittel, marking one of the largest…
-
EU-US trade deal leaves EFPIA’s lead “concerned for the future”
Following Trump’s decision to implement 15% import tariffs on goods from the EU, the US President has signed an agreement…
-
CSL slashes 15% of workforce and offshoots vaccine division
Australia’s largest pharmaceutical company CSL will reduce its headcount by 15% and spin off its vaccine division in response to…
-
Podcast: US tariff news and Q2 earnings influence pharma trends
After months of negotiations, the EU and US reached an agreement to levy a 15% tariff on EU imports, which…
-
US-China tensions offer new opportunity for APAC biotechs, report suggests
Investors are increasingly focused on biotech companies outside of China operating in the Asia-Pacific (APAC) market, according to a report…
-
New US-EU trade deal on tariffs ends pharma’s geopolitical immunity
For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the…
